Trial Profile
A Randomized, Double-Blind, Parallel-Group, 4-Arm, 12-Week Study to Evaluate the Safety and Efficacy of Topically Applied CTA018 vs Vehicle for the Treatment of Adult Subjects With Chronic Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2014
Price :
$35
*
At a glance
- Drugs Lunacalcipol (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors Cytochroma
- 22 May 2014 New trial record